Buchang Pharma

Heze, China Founded: 2001 • Age: 25 yrs Listed
Chinese medicines are researched, developed, manufactured, and supplied.

About Buchang Pharma

Buchang Pharma is a publicly listed company based in Heze (China) founded in 2001. Chinese medicines are researched, developed, manufactured, and supplied. Its website buchang.com draws about 31 thousand monthly visits. Buchang Pharma offers products and services including Cardiovascular Drugs and Diabetes Medications. Its focus areas include Alternative Medicine Products. Its legal entity is Shandong Buchang Pharmaceutical Co., Ltd.

Company details

Buchang Pharma, based in Heze, focuses on providing healthcare solutions, and alternative medicine products. Researcher, developer, manufacturer, and supplier of chinese medicines. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Heze, China
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website buchang.com
  • Legal Name Shandong Buchang Pharmaceuticals Co., Ltd. Class A
Key Metrics
  • Annual Revenue
    $1.68 B (USD)
    7.75
    as on Dec 31, 2025
  • Net Profit
    $51.53 M (USD)
    as on Dec 31, 2025
  • EBITDA
    $241.39 M (USD)
    30.43
    as on Dec 31, 2025
  • Investors

Products & Services of Buchang Pharma

Buchang Pharma offers a comprehensive portfolio of products and services, including Cardiovascular Drugs and Diabetes Medications.

Cardiovascular Drugs
Pharmaceutical Products

Drugs are developed for treating heart and cerebral vessel conditions using traditional Chinese medicine approaches.

Diabetes Medications
Pharmaceutical Products

Medications are provided for diabetes management as part of the company's focus on major disease areas.

Funding Insights of Buchang Pharma

  • Total Rounds 3
  • Investors Count 2

All 3 funding rounds of Buchang Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2011Series A––
Jun 2010Series A–Shanghai Changjiang Guohong Investment Management
–
Jan 2008Series A–Shanghai Changjiang Guohong Investment Management
–
Valuation history

2 investors in total: 2 institutional.

Investors in Buchang Pharma

Buchang Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include AIF Capital and Grand Yangtze.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investment funding and expertise for emerging businesses in Asia.
1994aifcapital.com
Private equity investments are managed by the company.
2012grandyangtze.comShanghai, China
Premium access

Investor details for Buchang Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of Buchang Pharma

Buchang Pharma is a publicly listed company on the SSE with ticker symbol 603858 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date18 Nov 2016
  • Listed onSSE: 603858
  • Listed entityShandong Buchang Pharmaceuticals Co., Ltd. Class A
  • Exchange sectorHealth technology
  • ISINCNE100002FV6
  • Share price14.60 CNY (-0.07% on the day) · 2026-10-14
  • Market capitalisation14,888,035,512.00 CNY
  • Price to earnings64.7
  • EPS (diluted, trailing year)0.23 CNY
  • Dividend yield3.85%
  • Volume (last session)2,772,338

Financials of Buchang Pharma

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202511.76B CNY360.8M CNY1.69B CNY
202410.92B CNY-553.8M CNY1.30B CNY
202313.11B CNY319.0M CNY1.65B CNY
202214.78B CNY-1.53B CNY2.30B CNY
202115.59B CNY1.29B CNY2.24B CNY
Premium access

Detailed financial statements for Buchang Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Buchang Pharma

4 dated milestones of Buchang Pharma across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Buchang Pharma is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A,.
  4. IPO Lists on the stock exchange (IPO).

Web traffic of Buchang Pharma

The website of Buchang Pharma (buchang.com) receives about 30.8K visits a month and ranks #572,102 among all websites worldwide, #599 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    30.8K
  • Unique visitors
    3.4K

    per month

  • Global rank
    #572,102

    among all websites

  • Category rank
    #599

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Buchang Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
zgylbx.com
zgylbx.com
100%
#4,610,925–
baxter.com.cn
baxter.com.cn
100%
#14,321,318–
sqys.com
sqys.com
66%
#6,479,190–
zryhyy.com.cn
zryhyy.com.cn
66%
–
healthcare.philips.com
healthcare.philips.com
66%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 20 similar websites and full traffic analytics for Buchang Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 20 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Buchang Pharma

Premium access

Complete news archive for Buchang Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Buchang Pharma

Buchang Pharma was founded in 2001 and raised its 1st funding round 7 years after it was founded.

Buchang Pharma is headquartered in Heze, China. It is registered at Heze, Shandong, China.

Annual revenue of Buchang Pharma is $1.68B as on Dec 31, 2025.

Buchang Pharma, based in Heze, focuses on providing healthcare solutions, and alternative medicine products. Researcher, developer, manufacturer, and supplier of chinese medicines. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Buchang Pharma offers Cardiovascular Drugs and Diabetes Medications.

Yes, Buchang Pharma is publicly traded on SSE under the ticker symbol 603858.

Buchang Pharma has 2 investors. Key investors include AIF Capital, and Grand Yangtze.

Buchang Pharma operates through Shandong Buchang Pharmaceutical Co., Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available